30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Myomo Inc (MYO)

Track

Over the last 90 days, Myomo Inc. saw significant insider activity with a net buy value of $299,510. While total buy transactions amounted to $331,750, sell transactions reached $187,179. Notably, executive net activity was negative at -$32,239. Recent transactions include substantial buys by KIRK THOMAS F and Joseph M. Manko Jr., alongside proposed sales by Officers Micah Mitchell and Harry Kovelman.
Stock chart
Ticker: MYO Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Harry Kovelman
Officer
1 sale — total 100,000 USD
Proposed sale 12 Jun 2026
Value US$1,425,875.78 | Price 236.05 | Shares 15,826
Proposed sale 12 Jun 2026
Value US$2,489,614.85 | Price 229.10 | Shares 25,553
Proposed sale 8 Jun 2026
Value US$100,000.00 | Price 1.33 | Shares 1,000
Proposed sale 8 Jun 2026
Value US$100,000.00 | Price 1.33 | Shares 1,000
Buy 5 Jun 2026
Value US$100,000.00 | Price 1.27 | Shares 1,000
Buy 28 May 2026
Value US$24,825.00 | Price 0.99 | Shares 25,000
Sale 28 May 2026
Value US$11,734.42 | Price 1.02 | Shares 11,536
Proposed sale 28 May 2026
Value US$11,734.42 | Price 1.02 | Shares 11,536
Sale 27 May 2026
Value US$20,504.93 | Price 1.00 | Shares 20,464
Proposed sale 27 May 2026
Value US$20,468.09 | Price 1.00 | Shares 20,464
Buy 18 May 2026
Value US$39,494.91 | Price 0.91 | Shares 43,401
Buy 15 May 2026
Value US$28,747.91 | Price 0.91 | Shares 31,605
Buy 15 May 2026
Value US$26,959.82 | Price 0.89 | Shares 30,367
Buy 14 May 2026
Value US$146,947.97 | Price 0.86 | Shares 170,830
Proposed sale 14 May 2026
Value US$77,688.89 | Price 0.86 | Shares 90,231
Proposed sale 13 Apr 2026
Value US$2,806.60 | Price 0.71 | Shares 3,953
Buy 16 Mar 2026
Value US$13,972.00 | Price 0.70 | Shares 20,000
Buy 13 Mar 2026
Value US$51,112.80 | Price 0.71 | Shares 72,000
Buy 12 Mar 2026
Value US$50,960.00 | Price 0.73 | Shares 70,000
Buy 21 Nov 2025
Value US$1,825.20 | Price 0.72 | Shares 2,535
Buy 20 Nov 2025
Value US$3,529.44 | Price 0.72 | Shares 4,902
Buy 19 Nov 2025
Value US$294.52 | Price 0.77 | Shares 385
Buy 18 Nov 2025
Value US$2,938.00 | Price 0.73 | Shares 4,000
Buy 25 Aug 2025
Value US$57,500.00 | Price 1.15 | Shares 50,000
Buy 18 Aug 2025
Value US$55,000.00 | Price 1.10 | Shares 50,000
Buy 15 Aug 2025
Value US$47,295.00 | Price 0.95 | Shares 50,000
Proposed sale 6 Jun 2025
Value US$17,056.71 | Price 2.97 | Shares 5,743
Proposed sale 6 Jun 2025
Value US$24,867.81 | Price 2.97 | Shares 8,373
Buy 15 May 2025
Value US$119,678.00 | Price 3.25 | Shares 36,824
Buy 15 May 2025
Value US$96,612.00 | Price 3.22 | Shares 30,000
Sale 14 May 2025
Value US$77,688.89 | Price 0.86 | Shares 90,231
Buy 14 May 2025
Value US$6,314.75 | Price 3.25 | Shares 1,943
Buy 12 May 2025
Value US$167,500.00 | Price 3.35 | Shares 50,000
Proposed sale 14 Mar 2025
Value US$247,565.36 | Price 5.16 | Shares 48,000
Sale 14 Mar 2025
Value US$247,564.80 | Price 5.16 | Shares 48,000
Buy 13 Mar 2025
Value US$37,000.00 | Price 5.00 | Shares 7,400
Proposed sale 13 Mar 2025
Value US$6,697.26 | Price 5.22 | Shares 1,283
Proposed sale 13 Mar 2025
Value US$10,539.18 | Price 5.22 | Shares 2,019
Proposed sale 13 Mar 2025
Value US$7,809.12 | Price 5.22 | Shares 1,496
Sale 12 Mar 2025
Value US$165,018.00 | Price 5.50 | Shares 30,000
Proposed sale 12 Mar 2025
Value US$165,015.00 | Price 5.50 | Shares 30,000
Proposed sale 4 Nov 2024
Value US$447.70 | Price 3.70 | Shares 121
Proposed sale 3 Oct 2024
Value US$467.06 | Price 3.86 | Shares 121
Sale 5 Sep 2024
Value US$25,182.62 | Price 3.76 | Shares 6,700
Proposed sale 4 Sep 2024
Value US$540.71 | Price 3.89 | Shares 139
Sale 3 Sep 2024
Value US$8,140.35 | Price 4.01 | Shares 2,029
Proposed sale 3 Sep 2024
Value US$74,000.00 | Price 4.00 | Shares 18,500
Proposed sale 5 Aug 2024
Value US$506.88 | Price 3.96 | Shares 128
Proposed sale 3 Jul 2024
Value US$344.85 | Price 2.85 | Shares 121
Proposed sale 1 Jul 2024
Value US$76,816.72 | Price 3.02 | Shares 25,436
Proposed sale 1 Jul 2024
Value US$46,810.00 | Price 3.02 | Shares 15,500
Proposed sale 1 Jul 2024
Value US$38,861.36 | Price 3.02 | Shares 12,868
Proposed sale 10 Jun 2024
Value US$18,102.60 | Price 3.39 | Shares 5,340
Proposed sale 10 Jun 2024
Value US$23,133.36 | Price 3.39 | Shares 6,824
Proposed sale 10 Jun 2024
Value US$35,930.61 | Price 3.39 | Shares 10,599
Proposed sale 3 Jun 2024
Value US$412.61 | Price 3.41 | Shares 121
Buy 29 May 2024
Value US$175,000.00 | Price 3.50 | Shares 50,000
Sale 15 May 2024
Value US$130,838.85 | Price 3.69 | Shares 35,426
Proposed sale 15 May 2024
Value US$130,835.30 | Price 3.69 | Shares 35,426
Proposed sale 3 May 2024
Value US$572.32 | Price 3.92 | Shares 146
Proposed sale 3 Apr 2024
Value US$442.38 | Price 3.03 | Shares 146
Buy 14 Mar 2024
Value US$175,000.00 | Price 3.50 | Shares 50,000
Proposed sale 11 Mar 2024
Value US$21,022.10 | Price 3.19 | Shares 6,590
Proposed sale 11 Mar 2024
Value US$24,799.06 | Price 3.19 | Shares 7,774
Proposed sale 11 Mar 2024
Value US$17,095.21 | Price 3.19 | Shares 5,359
Proposed sale 4 Mar 2024
Value US$582.86 | Price 3.86 | Shares 151
Proposed sale 5 Feb 2024
Value US$496.40 | Price 3.40 | Shares 146
Proposed sale 3 Jan 2024
Value US$694.55 | Price 4.79 | Shares 145
Proposed sale 8 Dec 2023
Value US$62,634.97 | Price 4.18 | Shares 14,997
Sale 8 Dec 2023
Value US$0.00 | Price 0.00 | Shares 14,997
Proposed sale 5 Dec 2023
Value US$402.93 | Price 4.07 | Shares 99
Sale 1 Dec 2023
Value US$0.00 | Price 0.00 | Shares 8,333
Proposed sale 1 Dec 2023
Value US$25,998.96 | Price 3.12 | Shares 8,333
Sale 28 Nov 2023
Value US$0.00 | Price 0.00 | Shares 14,997
Proposed sale 28 Nov 2023
Value US$49,424.11 | Price 3.30 | Shares 14,997
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-12 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
15,826
236.05
US$1,425,876 		15,826 236.05 US$1,425,876
2026-06-12 2026-06-12 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
25,553
229.10
US$2,489,615 		25,553 229.10 US$2,489,615
2026-06-08 2026-06-08 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
76,911
418.39
US$1,965,609 		76,911 418.39 US$1,965,609
2026-06-08 2026-06-08 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
1,000
1.33
US$100,000 		1,000 1.33 US$100,000
2026-06-09 2026-06-05 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
1,000 +6.1%
1.27
US$100,000 		1,000 +6.1% 1.27 US$100,000
2026-06-01 2026-05-28 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
25,000 +4.0%
0.99
US$24,825 		25,000 +4.0% 0.99 US$24,825
2026-05-28 2026-05-28 S Sale
3.4
Kovelman Harry

Chief Medical Officer

Officer
11,536 -9.6%
1.02
US$11,734 		11,536 -9.6% 1.02 US$11,734
2026-05-28 2026-05-28 PrS Proposed sale
3.4
HARRY KOVELMAN

Officer

Officer
11,536
1.02
US$11,734 		11,536 1.02 US$11,734
2026-05-28 2026-05-27 S Sale
3.4
Kovelman Harry

Chief Medical Officer

Officer
20,464 -14.6%
1.00
US$20,505 		20,464 -14.6% 1.00 US$20,505
2026-05-27 2026-05-27 PrS Proposed sale
3.4
HARRY KOVELMAN

Officer

Officer
20,464
1.00
US$20,468 		20,464 1.00 US$20,468
2026-05-18 2026-05-18 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
43,401 +7.4%
0.91
US$39,495 		43,401 +7.4% 0.91 US$39,495
2026-05-18 2026-05-15 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
31,605 +5.7%
0.91
US$28,748 		31,605 +5.7% 0.91 US$28,748
2026-05-18 2026-05-15 B Purchase
2.5
Manko Joseph M. Jr.
Non-Executive Director
30,367 +1.3%
0.89
US$26,960 		30,367 +1.3% 0.89 US$26,960
2026-05-18 2026-05-14 B Purchase
2.5
Manko Joseph M. Jr.
Non-Executive Director
170,830 +8.1%
0.86
US$146,948 		170,830 +8.1% 0.86 US$146,948
2026-05-14 2026-05-14 PrS Proposed sale
3.3
MICAH MITCHELL

Officer

Officer
90,231
0.86
US$77,689 		90,231 0.86 US$77,689
2026-04-13 2026-04-13 PrS Proposed sale
1.6
David Henry

Officer

Officer
3,953
0.71
US$2,807 		3,953 0.71 US$2,807
2026-03-17 2026-03-16 B Purchase
3.4
Getz Heather C
Non-Executive Director
20,000 +17.9%
0.70
US$13,972 		20,000 +17.9% 0.70 US$13,972
2026-03-16 2026-03-13 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
72,000 +14.9%
0.71
US$51,113 		72,000 +14.9% 0.71 US$51,113
2026-03-12 2026-03-12 B Purchase
3.4
Getz Heather C
Non-Executive Director
70,000 +167.6%
0.73
US$50,960 		70,000 +167.6% 0.73 US$50,960
2025-11-24 2025-11-21 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
2,535 +0.5%
0.72
US$1,825 		2,535 +0.5% 0.72 US$1,825
2025-11-24 2025-11-20 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
4,902 +1.0%
0.72
US$3,529 		4,902 +1.0% 0.72 US$3,529
2025-11-21 2025-11-19 B Purchase
3.2
Crowley Thomas Aloysius Jr.
Non-Executive Director
385 +409.6%
0.77
US$295 		385 +409.6% 0.77 US$295
2025-11-21 2025-11-18 B Purchase
3.2
Crowley Thomas Aloysius Jr.
Non-Executive Director
4,000 +5.6%
0.73
US$2,938 		4,000 +5.6% 0.73 US$2,938
2025-08-26 2025-08-25 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
50,000 +11.8%
1.15
US$57,500 		50,000 +11.8% 1.15 US$57,500
2025-08-19 2025-08-18 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
50,000 +13.4%
1.10
US$55,000 		50,000 +13.4% 1.10 US$55,000
2025-08-18 2025-08-15 B Purchase
3.6
GUDONIS PAUL R

Chief Executive Officer

Executive Director
50,000 +4.1%
0.95
US$47,295 		50,000 +4.1% 0.95 US$47,295
2025-06-06 2025-06-06 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
5,743
2.97
US$17,057 		5,743 2.97 US$17,057
2025-06-06 2025-06-06 PrS Proposed sale
1.6
David Henry

Officer

Officer
8,373
2.97
US$24,868 		8,373 2.97 US$24,868
2025-05-15 2025-05-15 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
36,824 +12.0%
3.25
US$119,678 		36,824 +12.0% 3.25 US$119,678
2025-05-15 2025-05-15 B Purchase
3.6
GUDONIS PAUL R

Chief Executive Officer

Executive Director
30,000 +2.9%
3.22
US$96,612 		30,000 +2.9% 3.22 US$96,612
2026-05-15 2025-05-14 S Sale
3.3
Mitchell Micah

Chief Commercial Officer

Officer
90,231 -45.2%
0.86
US$77,689 		90,231 -45.2% 0.86 US$77,689
2025-05-15 2025-05-14 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
1,943 +0.6%
3.25
US$6,315 		1,943 +0.6% 3.25 US$6,315
2025-05-14 2025-05-12 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
50,000 +19.5%
3.35
US$167,500 		50,000 +19.5% 3.35 US$167,500
2025-03-14 2025-03-14 PrS Proposed sale
3.3
MICAH MITCHELL

Officer

Officer
48,000
5.16
US$247,565 		48,000 5.16 US$247,565
2025-03-14 2025-03-14 S Sale
3.3
Mitchell Micah

Chief Commercial Officer

Officer
48,000 -25.5%
5.16
US$247,565 		48,000 -25.5% 5.16 US$247,565
2025-03-14 2025-03-13 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
7,400 +3.0%
5.00
US$37,000 		7,400 +3.0% 5.00 US$37,000
2025-03-13 2025-03-13 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
1,283
5.22
US$6,697 		1,283 5.22 US$6,697
2025-03-13 2025-03-13 PrS Proposed sale
1.6
David Henry

Officer

Officer
2,019
5.22
US$10,539 		2,019 5.22 US$10,539
2025-03-13 2025-03-13 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
1,496
5.22
US$7,809 		1,496 5.22 US$7,809
2025-03-13 2025-03-12 S Sale
3.4
Kovelman Harry

Chief Medical Officer

Officer
30,000 -23.4%
5.50
US$165,018 		30,000 -23.4% 5.50 US$165,018
2025-03-12 2025-03-12 PrS Proposed sale
3.4
HARRY KOVELMAN

Officer

Officer
30,000
5.50
US$165,015 		30,000 5.50 US$165,015
2024-11-04 2024-11-04 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
121
3.70
US$448 		121 3.70 US$448
2024-10-03 2024-10-03 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
121
3.86
US$467 		121 3.86 US$467
2024-09-09 2024-09-05 S Sale
3.4
Kovelman Harry

Chief Medical Officer

Officer
6,700 -5.1%
3.76
US$25,183 		6,700 -5.1% 3.76 US$25,183
2024-09-04 2024-09-04 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
139
3.89
US$541 		139 3.89 US$541
2024-09-05 2024-09-03 S Sale
3.4
Kovelman Harry

Chief Medical Officer

Officer
2,029 -1.5%
4.01
US$8,140 		2,029 -1.5% 4.01 US$8,140
2024-09-03 2024-09-03 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
18,500
4.00
US$74,000 		18,500 4.00 US$74,000
2024-08-05 2024-08-05 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
128
3.96
US$507 		128 3.96 US$507
2024-07-03 2024-07-03 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
121
2.85
US$345 		121 2.85 US$345
2024-07-01 2024-07-01 PrS Proposed sale
1.6
David Henry

Officer

Officer
25,436
3.02
US$76,817 		25,436 3.02 US$76,817
2024-07-01 2024-07-01 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
15,500
3.02
US$46,810 		15,500 3.02 US$46,810
2024-07-01 2024-07-01 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
12,868
3.02
US$38,861 		12,868 3.02 US$38,861
2024-06-10 2024-06-10 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
5,340
3.39
US$18,103 		5,340 3.39 US$18,103
2024-06-10 2024-06-10 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
6,824
3.39
US$23,133 		6,824 3.39 US$23,133
2024-06-10 2024-06-10 PrS Proposed sale
1.6
David Henry

Officer

Officer
10,599
3.39
US$35,931 		10,599 3.39 US$35,931
2024-06-03 2024-06-03 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
121
3.41
US$413 		121 3.41 US$413
2024-05-31 2024-05-29 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
50,000 +26.8%
3.50
US$175,000 		50,000 +26.8% 3.50 US$175,000
2024-05-17 2024-05-15 S Sale
3.4
Kovelman Harry

Chief Medical Officer

Officer
35,426 -26.5%
3.69
US$130,839 		35,426 -26.5% 3.69 US$130,839
2024-05-15 2024-05-15 PrS Proposed sale
3.4
HARRY KOVELMAN

Officer

Officer
35,426
3.69
US$130,835 		35,426 3.69 US$130,835
2024-05-03 2024-05-03 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
146
3.92
US$572 		146 3.92 US$572
2024-04-02 2024-04-03 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
146
3.03
US$442 		146 3.03 US$442
2024-03-18 2024-03-14 B Purchase
2.5
KIRK THOMAS F
Non-Executive Director
50,000 +36.6%
3.50
US$175,000 		50,000 +36.6% 3.50 US$175,000
2024-03-11 2024-03-11 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
6,590
3.19
US$21,022 		6,590 3.19 US$21,022
2024-03-11 2024-03-11 PrS Proposed sale
1.6
David Henry

Officer

Officer
7,774
3.19
US$24,799 		7,774 3.19 US$24,799
2024-03-11 2024-03-11 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
5,359
3.19
US$17,095 		5,359 3.19 US$17,095
2024-03-04 2024-03-04 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
151
3.86
US$583 		151 3.86 US$583
2024-02-02 2024-02-05 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
146
3.40
US$496 		146 3.40 US$496
2024-01-02 2024-01-03 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
145
4.79
US$695 		145 4.79 US$695
2023-12-08 2023-12-08 PrS Proposed sale
3.2
THOMAS CROWLEY JR

Director

Non-Executive Director
14,997
4.18
US$62,635 		14,997 4.18 US$62,635
2023-12-08 2023-12-08 S Sale
3.2
Crowley Thomas Aloysius Jr.
Non-Executive Director
14,997
0.00
US$0 		14,997 0.00 US$0
2023-12-04 2023-12-05 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
99
4.07
US$403 		99 4.07 US$403
2023-12-05 2023-12-01 S Sale
3.4
Kovelman Harry

Chief Medical Officer

Officer
8,333
0.00
US$0 		8,333 0.00 US$0
2023-12-04 2023-12-01 PrS Proposed sale
3.4
Harry Kovelman

Officer

Officer
8,333
3.12
US$25,999 		8,333 3.12 US$25,999
2023-11-30 2023-11-28 S Sale
3.2
Crowley Thomas Aloysius Jr.
Non-Executive Director
14,997
0.00
US$0 		14,997 0.00 US$0
2023-11-28 2023-11-28 PrS Proposed sale
3.2
THOMAS CROWLEY JR

Director

Non-Executive Director
14,997
3.30
US$49,424 		14,997 3.30 US$49,424
Explore more

More insider trading research around Myomo Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America